Stericycle (SRCL) Stock Price, News & Analysis

Company Overview

Stericycle, Inc., together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions. It also provides secure information destruction services, including document, hard drive, destruction services under the Shred-it brand. The company serves healthcare businesses, including hospitals, health systems, non-affiliate hospitals, national and corporate healthcare, physician offices, surgery centers, veterinary and dental clinics, nursing and long-term care facilities, clinics and urgent care, dialysis centers, pharmacy, lab, research centers, home health organizations, etc.; and airports and seaports, education institutions, funeral homes and crematories, government and military, banks and professional services, and other businesses. Stericycle, Inc. was incorporated in 1989 and is headquartered in Bannockburn, Illinois.

Key Stats

• Today's Range: $61.98 to $61.98
• 50-Day Range: $60.81 to $61.98
• 52-Week Range: $37.78 to $61.99
• Volume: N/A
• Average Volume: 1.14 million shs
• Market Capitalization: $5.75 billion
• P/E Ratio: 163.11
• Dividend Yield: N/A
• Price Target: $80.25
• Consensus Rating: Hold

Stericycle Stock Analysis - MarketRank™

Stericycle scored higher than 64% of companies evaluated by MarketBeat, and ranked 133rd out of 329 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.1 / 5
• Analyst Rating: Hold

Consensus Rating

Stericycle has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Stericycle has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 15.28%

Earnings Growth

Earnings for Stericycle are expected to grow by 15.28% in the coming year, from $2.29 to $2.64 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Stericycle is 163.11, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.65.

Price to Earnings Ratio vs. Sector

The P/E ratio of Stericycle is 163.11, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 32.46.

Price to Earnings Growth Ratio

Stericycle has a PEG Ratio of 3.38. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Stericycle has a P/B Ratio of 2.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for SRCL.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Stericycle does not currently pay a dividend.

Dividend Growth

Stericycle does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -1.10

Short Interest

There is no current short interest data available for SRCL.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Stericycle insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.93% of the stock of Stericycle is held by insiders.

Percentage Held by Institutions

98.82% of the stock of Stericycle is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SRCL Stock Analysis - Frequently Asked Questions

How were Stericycle's earnings last quarter?

Stericycle, Inc. (NASDAQ:SRCL) announced its quarterly earnings results on Thursday, April, 25th. The business services provider reported $0.57 earnings per share for the quarter, beating analysts' consensus estimates of $0.54 by $0.03. Stericycle's quarterly revenue was down 2.8% compared to the same quarter last year.

Does Stericycle have any subsidiaries?

Stericycle subsidiaries include these companies: LiveAnswer, InQuicker, Shred-it, PSC Environmental Service, Healthcare Waste Solutions, MedServe, Ambimed - Gestao Ambiental Lda., and more.

Who are Stericycle's major shareholders?

Top institutional shareholders of Stericycle include Kentucky Retirement Systems Insurance Trust Fund, Blue Trust Inc., Blue Trust Inc. and Avior Wealth Management LLC.
View institutional ownership trends.

What other stocks do shareholders of Stericycle own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Stericycle investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Home Depot (HD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Intel (INTC).

Company Calendar

• Last Earnings: 4/25/2024
• Today: 3/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Sanitary services
• Sub-Industry: Environmental & Facilities Services
• Current Symbol: NASDAQ:SRCL
• CIK: 861878
• Web: www.stericycle.com
• Phone: (847) 367-5910
• Fax: 847-367-9493
• Employees: 13,500
• Year Founded: 1989

Price Target and Rating

• Average Stock Price Target: $80.25
• High Stock Price Target: $142.00
• Low Stock Price Target: $55.00
• Potential Upside/Downside: +29.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.38
• Trailing P/E Ratio: 163.11
• Forward P/E Ratio: 27.07
• P/E Growth: 3.38
• Net Income: $-21,400,000.00
• Net Margins: 0.77%
• Pretax Margin: 1.50%
• Return on Equity: 5.78%
• Return on Assets: 2.69%

Debt

• Debt-to-Equity Ratio: 0.53
• Current Ratio: 1.20
• Quick Ratio: 1.13

Sales & Book Value

• Annual Sales: $2.66 billion
• Price / Sales: 2.16
• Cash Flow: $4.23 per share
• Price / Cash Flow: 14.64
• Book Value: $27.52 per share
• Price / Book: 2.25

Miscellaneous

• Outstanding Shares: 92,840,000
• Free Float: 91,973,000
• Market Cap: $5.75 billion
• Optionable: Optionable
• Beta: 1.10